TY - JOUR
T1 - Antitrypanosomal activity & docking studies of components of Crateva adansonii DC leaves
T2 - novel multifunctional scaffolds
AU - Igoli, Ngozichukwuka Peace
AU - Clements, Carol Jean
AU - Singla, Rajeev Kumar
AU - Igoli, John Ogbaji
AU - Uche, Nzekwe Uche
AU - Gray, Alexander Irvine
PY - 2014
Y1 - 2014
N2 - Chemical investigation of Crateva adansonii DC has led to the isolation of aurantiamide acetate, a novel ethyl pyropheophorbide A, purpurin-18 ethyl ester and pyropheophorbide A. Their structures were elucidated using extensive spectral data. These metabolites were then evaluated for their in vitro bioactivity against the African trypanosome Trypanosoma brucei brucei (S427) blood stream forms. Anti-trypanosomal activity decreased with aurantiamide acetate (MIC 25μM), while it increased with the pheopytins (MIC 6.25μM), when compared to the standard drug Suramin. Using the Vlife MDS 4.3 - GRIP docking, these phytoconstituents were then tested to identify the proteins targeted and the mode of activity employed. Their affinity towards the receptor sites of trypanothione reductase, riboflavin kinase, rohedsain, glutathione synthetase & sterol-14α-demethylase (CYP51) of Trypanosoma brucei were evaluated according to the resulting docking energies.
AB - Chemical investigation of Crateva adansonii DC has led to the isolation of aurantiamide acetate, a novel ethyl pyropheophorbide A, purpurin-18 ethyl ester and pyropheophorbide A. Their structures were elucidated using extensive spectral data. These metabolites were then evaluated for their in vitro bioactivity against the African trypanosome Trypanosoma brucei brucei (S427) blood stream forms. Anti-trypanosomal activity decreased with aurantiamide acetate (MIC 25μM), while it increased with the pheopytins (MIC 6.25μM), when compared to the standard drug Suramin. Using the Vlife MDS 4.3 - GRIP docking, these phytoconstituents were then tested to identify the proteins targeted and the mode of activity employed. Their affinity towards the receptor sites of trypanothione reductase, riboflavin kinase, rohedsain, glutathione synthetase & sterol-14α-demethylase (CYP51) of Trypanosoma brucei were evaluated according to the resulting docking energies.
KW - antitrypanosomal activity
KW - aurantiamide acetate
KW - crateva adansonii DC
KW - ethyl pyropheophorbide A
KW - GRIP docking
KW - purpurin-18 ethyl ester
KW - pyropheophorbide A
U2 - 10.2174/1568026614666140324120006
DO - 10.2174/1568026614666140324120006
M3 - Article
SN - 1568-0266
VL - 14
SP - 981
EP - 990
JO - Current Topics in Medicinal Chemistry
JF - Current Topics in Medicinal Chemistry
IS - 8
ER -